Quince Therapeutics, Inc. Other Executive Compensation Disclosures
Every other executive-compensation XBRL fact the company filed (policies, award timing, footnotes, adjustments), newest first. Long text is shortened; the filing has the full text.
- 2023-04-14: Disclosure Pay versus Performance Table; Period 2022-01-01..2022-12-31; Value PAY VERSUS PERFORMANCE As required by Section 953(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and Item 402(v) of Regulation S-K, we are providing the following information about the relationship between executive compensation actually paid and certain financial performance o….
- 2023-04-14: Disclosure PEO Total Compensation; Qualifiers Individual: DirkThyeM.d.; Period 2022-01-01..2022-12-31; Value $4.97M.
- 2023-04-14: Disclosure PEO Total Compensation; Qualifiers Individual: ChristopherLowe; Period 2022-01-01..2022-12-31; Value $3.40M.
- 2023-04-14: Disclosure PEO Total Compensation; Qualifiers Individual: CaseyC.Lynch; Period 2022-01-01..2022-12-31; Value $5.17M.
| Filed | Disclosure | Qualifiers | Period | Value |
|---|---|---|---|---|
| 2023-04-14 DEF 14A | Pay versus Performance Table | 2022-01-01..2022-12-31 | PAY VERSUS PERFORMANCE As required by Section 953(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and Item 402(v) of Regulation S-K, we are providing the following information about the relationship between executive compensation actually paid and certain financial performance o… | |
| 2023-04-14 DEF 14A | PEO Total Compensation | Individual: DirkThyeM.d. | 2022-01-01..2022-12-31 | $4.97M |
| 2023-04-14 DEF 14A | PEO Total Compensation | Individual: ChristopherLowe | 2022-01-01..2022-12-31 | $3.40M |
| 2023-04-14 DEF 14A | PEO Total Compensation | Individual: CaseyC.Lynch | 2022-01-01..2022-12-31 | $5.17M |
| 2023-04-14 DEF 14A | PEO Actually Paid Compensation | Individual: DirkThyeM.d. | 2022-01-01..2022-12-31 | $1.79M |
| 2023-04-14 DEF 14A | PEO Actually Paid Compensation | Individual: ChristopherLowe | 2022-01-01..2022-12-31 | -$742.80K |
| 2023-04-14 DEF 14A | PEO Actually Paid Compensation | Individual: CaseyC.Lynch | 2022-01-01..2022-12-31 | -$1.87M |
| 2023-04-14 DEF 14A | PEO Total Compensation | Individual: DirkThyeM.d. | 2021-01-01..2021-12-31 | $0.00 |
| 2023-04-14 DEF 14A | PEO Total Compensation | Individual: ChristopherLowe | 2021-01-01..2021-12-31 | $0.00 |
| 2023-04-14 DEF 14A | PEO Total Compensation | Individual: CaseyC.Lynch | 2021-01-01..2021-12-31 | $887.34K |
| 2023-04-14 DEF 14A | PEO Actually Paid Compensation | Individual: DirkThyeM.d. | 2021-01-01..2021-12-31 | $0.00 |
| 2023-04-14 DEF 14A | PEO Actually Paid Compensation | Individual: ChristopherLowe | 2021-01-01..2021-12-31 | $0.00 |
| 2023-04-14 DEF 14A | PEO Actually Paid Compensation | Individual: CaseyC.Lynch | 2021-01-01..2021-12-31 | -$2.85M |
| 2023-04-14 DEF 14A | Adjustment To PEO Compensation Footnote | 2022-01-01..2022-12-31 | (3) The dollar amounts reported in column (c) represent the amount of “compensation actually paid” to Dr. Thye, Mr. Lowe and Ms. Lynch, respectively, as computed in accordance with Item 402(v) of Regulation S-K. The dollar amounts do not reflect the actual amount of compensation earned by or paid to… | |
| 2023-04-14 DEF 14A | PEO Name | Individual: DirkThyeM.d. | 2022-01-01..2022-12-31 | Dirk Thye, M.D. |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: ReportedValueOfEquityAwards; ExecutiveCategory: Peo; Individual: DirkThyeM.d. | 2022-01-01..2022-12-31 | $4.48M |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardAdjustments; ExecutiveCategory: Peo; Individual: DirkThyeM.d. | 2022-01-01..2022-12-31 | $1.30M |
| 2023-04-14 DEF 14A | PEO Name | Individual: ChristopherLowe | 2022-01-01..2022-12-31 | Christopher Lowe |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: ReportedValueOfEquityAwards; ExecutiveCategory: Peo; Individual: ChristopherLowe | 2022-01-01..2022-12-31 | $1.99M |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardAdjustments; ExecutiveCategory: Peo; Individual: ChristopherLowe | 2022-01-01..2022-12-31 | -$1.40M |
| 2023-04-14 DEF 14A | PEO Name | Individual: CaseyC.Lynch | 2022-01-01..2022-12-31 | Casey C. Lynch |
| 2023-04-14 DEF 14A | PEO Name | Individual: CaseyC.Lynch | 2021-01-01..2021-12-31 | Casey C. Lynch |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: ReportedValueOfEquityAwards; ExecutiveCategory: Peo; Individual: CaseyC.Lynch | 2022-01-01..2022-12-31 | $4.36M |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardAdjustments; ExecutiveCategory: Peo; Individual: CaseyC.Lynch | 2022-01-01..2022-12-31 | -$2.68M |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: ReportedValueOfEquityAwards; ExecutiveCategory: Peo; Individual: CaseyC.Lynch | 2021-01-01..2021-12-31 | $0.00 |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardAdjustments; ExecutiveCategory: Peo; Individual: CaseyC.Lynch | 2021-01-01..2021-12-31 | -$3.73M |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: YearEndFairValueOfEquityAwards; ExecutiveCategory: Peo; Individual: DirkThyeM.d. | 2022-01-01..2022-12-31 | $1.24M |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwards; ExecutiveCategory: Peo; Individual: DirkThyeM.d. | 2022-01-01..2022-12-31 | $0.00 |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYear; ExecutiveCategory: Peo; Individual: DirkThyeM.d. | 2022-01-01..2022-12-31 | $65.47K |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYear; ExecutiveCategory: Peo; Individual: DirkThyeM.d. | 2022-01-01..2022-12-31 | $0.00 |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYear; ExecutiveCategory: Peo; Individual: DirkThyeM.d. | 2022-01-01..2022-12-31 | $0.00 |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: ValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsNotOtherwiseReflectedInFairValueOrTotalCompensation; ExecutiveCategory: Peo; Individual: DirkThyeM.d. | 2022-01-01..2022-12-31 | $0.00 |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: TotalEquityAwardAdjustments; ExecutiveCategory: Peo; Individual: DirkThyeM.d. | 2022-01-01..2022-12-31 | $1.30M |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: YearEndFairValueOfEquityAwards; ExecutiveCategory: Peo; Individual: ChristopherLowe | 2022-01-01..2022-12-31 | $0.00 |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwards; ExecutiveCategory: Peo; Individual: ChristopherLowe | 2022-01-01..2022-12-31 | $0.00 |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYear; ExecutiveCategory: Peo; Individual: ChristopherLowe | 2022-01-01..2022-12-31 | $578.62K |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYear; ExecutiveCategory: Peo; Individual: ChristopherLowe | 2022-01-01..2022-12-31 | -$306.15K |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYear; ExecutiveCategory: Peo; Individual: ChristopherLowe | 2022-01-01..2022-12-31 | -$1.67M |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: ValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsNotOtherwiseReflectedInFairValueOrTotalCompensation; ExecutiveCategory: Peo; Individual: ChristopherLowe | 2022-01-01..2022-12-31 | $0.00 |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: TotalEquityAwardAdjustments; ExecutiveCategory: Peo; Individual: ChristopherLowe | 2022-01-01..2022-12-31 | -$1.40M |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: YearEndFairValueOfEquityAwards; ExecutiveCategory: Peo; Individual: CaseyC.Lynch | 2022-01-01..2022-12-31 | $0.00 |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwards; ExecutiveCategory: Peo; Individual: CaseyC.Lynch | 2022-01-01..2022-12-31 | $0.00 |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYear; ExecutiveCategory: Peo; Individual: CaseyC.Lynch | 2022-01-01..2022-12-31 | $39.76K |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYear; ExecutiveCategory: Peo; Individual: CaseyC.Lynch | 2022-01-01..2022-12-31 | -$646.00 |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYear; ExecutiveCategory: Peo; Individual: CaseyC.Lynch | 2022-01-01..2022-12-31 | -$2.72M |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: ValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsNotOtherwiseReflectedInFairValueOrTotalCompensation; ExecutiveCategory: Peo; Individual: CaseyC.Lynch | 2022-01-01..2022-12-31 | $0.00 |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: TotalEquityAwardAdjustments; ExecutiveCategory: Peo; Individual: CaseyC.Lynch | 2022-01-01..2022-12-31 | -$2.68M |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: YearEndFairValueOfEquityAwards; ExecutiveCategory: Peo; Individual: CaseyC.Lynch | 2021-01-01..2021-12-31 | $0.00 |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwards; ExecutiveCategory: Peo; Individual: CaseyC.Lynch | 2021-01-01..2021-12-31 | -$7.49M |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYear; ExecutiveCategory: Peo; Individual: CaseyC.Lynch | 2021-01-01..2021-12-31 | $0.00 |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYear; ExecutiveCategory: Peo; Individual: CaseyC.Lynch | 2021-01-01..2021-12-31 | $3.76M |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYear; ExecutiveCategory: Peo; Individual: CaseyC.Lynch | 2021-01-01..2021-12-31 | $0.00 |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: ValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsNotOtherwiseReflectedInFairValueOrTotalCompensation; ExecutiveCategory: Peo; Individual: CaseyC.Lynch | 2021-01-01..2021-12-31 | $0.00 |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: TotalEquityAwardAdjustments; ExecutiveCategory: Peo; Individual: CaseyC.Lynch | 2021-01-01..2021-12-31 | -$3.73M |
| 2023-04-14 DEF 14A | Named Executive Officers Footnote | 2022-01-01..2022-12-31 | The dollar amounts reported in column (d) represent the average of the amounts reported for the Company’s named executive officers (“NEOs”) as a group (excluding, in the case of 2022, Dr. Thye, Mr. Lowe and Ms. Lynch, and in the case of 2021, Ms. Lynch) in the “Total” column of the Summary Compensat… | |
| 2023-04-14 DEF 14A | Adjustment To Non PEO NEO Compensation Footnote | 2022-01-01..2022-12-31 | (5) The dollar amounts reported in column (e) represent the average amount of “compensation actually paid” to the NEOs as a group (excluding, in the case of 2022, Dr. Thye, Mr. Lowe and Ms. Lynch, and in the case of 2021, Ms. Lynch), as computed in accordance with Item 402(v) of Regulation S-K. The … | |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: ReportedValueOfEquityAwards; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | $1.91M |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardAdjustments; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | -$288.56K |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: ReportedValueOfEquityAwards; ExecutiveCategory: NonPeoNeo | 2021-01-01..2021-12-31 | $369.50K |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: EquityAwardAdjustments; ExecutiveCategory: NonPeoNeo | 2021-01-01..2021-12-31 | -$2.43M |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: YearEndFairValueOfEquityAwards; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | $291.92K |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwards; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | $0.00 |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYear; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | $147.46K |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYear; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | -$117.79K |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYear; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | -$610.15K |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: ValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsNotOtherwiseReflectedInFairValueOrTotalCompensation; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | $0.00 |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: TotalEquityAwardAdjustments; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | -$288.56K |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: YearEndFairValueOfEquityAwards; ExecutiveCategory: NonPeoNeo | 2021-01-01..2021-12-31 | $69.39K |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwards; ExecutiveCategory: NonPeoNeo | 2021-01-01..2021-12-31 | -$4.28M |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: FairValueAsOfVestingDateOfEquityAwardsGrantedAndVestedInTheYear; ExecutiveCategory: NonPeoNeo | 2021-01-01..2021-12-31 | $82.27K |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedInTheYear; ExecutiveCategory: NonPeoNeo | 2021-01-01..2021-12-31 | $1.70M |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: FairValueAtTheEndOfThePriorYearOfEquityAwardsThatFailedToMeetVestingConditionsInTheYear; ExecutiveCategory: NonPeoNeo | 2021-01-01..2021-12-31 | $0.00 |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: ValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsNotOtherwiseReflectedInFairValueOrTotalCompensation; ExecutiveCategory: NonPeoNeo | 2021-01-01..2021-12-31 | $0.00 |
| 2023-04-14 DEF 14A | Adjustment To Compensation | AdjToComp: TotalEquityAwardAdjustments; ExecutiveCategory: NonPeoNeo | 2021-01-01..2021-12-31 | -$2.43M |
| 2023-04-14 DEF 14A | Compensation Actually Paid Vs Total Shareholder Return | 2022-01-01..2022-12-31 | Compensation Actually Paid and Cumulative TSR The following graph sets forth the relationship between Compensation Actually Paid to our PEOs, the average of Compensation Actually Paid to our other NEOs, and the Company’s cumulative TSR over the two most recently completed fiscal years. | |
| 2023-04-14 DEF 14A | Compensation Actually Paid Vs Net Income | 2022-01-01..2022-12-31 | Compensation Actually Paid and Net Income (Loss) The following graph sets forth the relationship between Compensation Actually Paid to our PEOs, the average of Compensation Actually Paid to our other NEOs, and the Company’s net income (loss) over the two most recently completed fiscal years. |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |